Chris Murphy actually said...
We can do all of this work on trying to make sure that we approve biosimilars, but if they're not actually getting prescribed, if we aren't giving FDA the resources to make the case that they should be prescribed, we're going to be spending billions and billions of additional dollars that we don't need to simply because we're continuing to funnel money to the makers of the original product who are in competition with the maker of the biosimilar.
Context
Senator Murphy warns about financial implications if biosimilars are not prescribed.
09/16/2015